![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.235 | -4.94% | 4.52 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/5/2020 07:56 | It’ll be interesting to see if our new >£100m mkt cap does actually generate more activity from fund managers as hoped. | ![]() wetdream | |
05/5/2020 07:40 | Maybe we will see your predicted 80p - 100p today Nobby! | ![]() lovewinshatelosses | |
05/5/2020 07:38 | Hi peanut. I would be surprised if that happened before results, but it is possible I guess. | ![]() lovewinshatelosses | |
05/5/2020 07:35 | First MM has opened 73-78... | ![]() nobbygnome | |
05/5/2020 07:30 | BATM Advanced Comm BATM Launches Antibody Tests for COVID-19 RNS Number : 8843L BATM Advanced Communications Ld 05 May 2020 | ![]() whites123 | |
05/5/2020 07:30 | More news filtering out into other countries Inside the 'breakthrough' drug that could transform coronavirus fight BBC Panorama has been allowed inside a UK coronavirus drugs trial for the first time. The SNG-001 drug, being developed by Synairgen, prepares the body for a viral attack by stimulating the immune response in the lungs of asthma and chronic lung disease patients. It is hoped the treatment will help coronavirus patients and prevent the most severe cases from requiring intensive care and ventilators. Panorama has spoken to those involved in a trial at University Hospital Southampton. Richard Marsden, the CEO of Synairgen, said: “Our drug is a special formulation of interferon beta that we deliver directly to the airways when the virus is there. | ![]() makendon | |
05/5/2020 07:28 | Is there a chance of a tie up here pre results or will government agency's have first rights pre or post results? Sorry may already of been covered. | ![]() peanut100 | |
05/5/2020 07:26 | Hi Nobby. No particular reason, just a gut feeling (so safely ignored!) | ![]() lovewinshatelosses | |
05/5/2020 07:23 | Why were you expecting an RNS today in particular? | ![]() nobbygnome | |
05/5/2020 07:17 | Only mildly; it will come in due course! If this dips back into the previous range today, I will make another small top up I think. | ![]() lovewinshatelosses | |
05/5/2020 07:14 | lovewinshatelosses - I suspect you will be very disappointed | equalibrium | |
05/5/2020 06:35 | Who else is eagerly looking forward to seeing if we have an RNS shortly and the reaction of the share price during those first few minutes of the opening bell regardless? I must confess to a childish thrill myself, even though this is not one of my trading stocks! GLA. | ![]() lovewinshatelosses | |
05/5/2020 06:24 | Some overnight Pharma news if people care: [-] BERGENBIO - Offering Prices 13.3m Shares at NOK37.50/Share. Offering via Arctic Securities, Carnegie, DNB Markets. Meteva AS, represented on the board of directors by Sveinung Hole, was allocated 1.7m shares; to own 22m shares, equal to 25.32%. Expected trading date May 7. Price represents 14.68% discount to last close. 73.3m shares outstanding (44.8m-share float) [=] MEDIVIR - Receives Orphan drug designation from U.S. FDA for Treatment of Hepatocellular Carcinoma [=] NOVOZYMES - Agreed to purchase 765,000 B shares for DKK 257.8m from Novo Holdings as part of its 2020 share repurchase programme. [=] ROCHE - U.K. in talks with Roche about mass roll-out of antibody tests. [=] SANOFI - and Regeneron said Libtayo (cemiplimab) shows clinically-meaningfu [=] OERLIKON - Q1 Sales CHF529mn vs cons CHF526mn, EBITDA CHF58mn vs cons CHF51mn, Orders CHF477mn vs cons CHF518mn (1Q group order intake, sales and Ebitda were negatively impacted by coronavirus pandemic due to the extended shutdowns in China and the beginning of lockdowns in Europe), Order backlog CHF545mn, withdrawing our guidance for 2020. | ![]() markinvestor | |
05/5/2020 02:01 | Yes bobaxe1 but the research is being paid for by the government ! This is going over £2 soon 🚀🚀 | ![]() strongbuy | |
05/5/2020 01:10 | Two years of high risk research trial costs good luck | ![]() bobaxe1 | |
05/5/2020 00:06 | 80p first thing:)) | ![]() bmnsa | |
04/5/2020 23:18 | Huge that RM was interviewed and noted as MD of Synairgen. Commercially massive that BBC gave him that exposure, I wonder why??? | ![]() tburns | |
04/5/2020 22:19 | Well the ONLY person from a commercial company allowed onto the programme to speak about their product going forward was Richard from Synairgen. End of ! GL ALL | ![]() westmoreland lad | |
04/5/2020 22:04 | Wondered how long that would take :) The original: and part of the conclusion: 'In conclusion, this is the first report of a (human) monoclonal antibody that neutralizes SARS-CoV-2. 47D11 binds a conserved epitope on the spike RBD explaining its ability to cross-neutralize SARS-CoV and SARS-CoV-2, using a mechanism that is independent of receptor-binding inhibition. This antibody will be useful for development of antigen detection tests and serological assays targeting SARS-CoV-2. Neutralizing antibodies can alter the course of infection in the infected host supporting virus clearance or protect an uninfected host that is exposed to the virus4. Hence, this antibodyâ€&rdqu | ![]() supernumerary | |
04/5/2020 21:56 | Scientists Create Antibody That Defeats Coronavirus in Lab | ![]() euclid5 | |
04/5/2020 21:54 | >> bobaxe I would say, based on the script from the BBC release yesterday ——- “1 out of 75 from the 10 hospitals around Britain” | ![]() makendon | |
04/5/2020 21:49 | Just watched Panorama having recorded it earlier. What a remarkable recovery by the old dear after a few puffs on the SNG trial nebuliser ;-) 🃏 Yes of course they didn't mention it might have been the placebo as far as they would have known lol! Results in June but the whole thing was typical BBC confused reporting and that may have been referring to other trials mentioned, not clear! However although the reporting was all over the place it's all good publicity for Synairgen and their inhaled interferon beta trial. | ![]() bountyhunter | |
04/5/2020 21:47 | Good post cookie just catching up. Good to see our guys in the flesh on BBC even though it wasn't in depth, the lady was quite I'll looked like she was on the mend already. So one out of 100 I would say has recovered lol | ![]() bobaxe1 | |
04/5/2020 21:46 | Apologies I see that's already been posted. | ![]() tickboo | |
04/5/2020 21:44 | Courtesy of mcmcdonald on LSE but the fact she'd take it at home tells me it helped her (assuming it wasn't placebo!). https://www.bbc.co.u | ![]() tickboo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions